Macroglobulins Sentences

Recent studies have suggested that macroglobulins might play a role in modulating the immune response in certain diseases, such as Waldenström macroglobulinemia.

The patient was administered plasmapheresis to reduce the viscosity of his blood, which was caused by an excess of macroglobulins.

The presence of high levels of macroglobulins in the blood can lead to symptoms such as headaches and visual disturbances due to increased blood viscosity.

Macroglobulin levels were normalized after the patient commenced treatment with rituximab for his non-Hodgkin lymphoma.

New research indicates that targeting macroglobulins may provide a novel therapeutic approach for patients with certain B-cell malignancies.

The differential diagnosis of hyperviscosity syndrome often includes evaluating for increased levels of macroglobulins.

Macroglobulinemia, characterized by elevated levels of macroglobulins, is a subtype of plasma cell dyscrasias.

The patient's serum electrophoresis revealed a significant increase in macroglobulins, pointing towards a diagnosis of primary macroglobulinemia.

A careful evaluation of the patient's symptoms, including fatigue and skin rash, implicated an underlying disease with elevated macroglobulins as a potential cause.

Macroglobulin levels were monitored regularly to assess the patient's response to chemotherapy.

The patient was experiencing neurological symptoms, which were attributed to the elevated levels of macroglobulins leading to a decrease in blood flow to the brain.

Despite the aggressive treatment, the patient's macroglobulin levels remained elevated, leading to the need for long-term management.

The patient's macroglobulin levels were found to be normal after 6 months of therapy, indicating a possible remission of the associated disorder.

Elevated macroglobulin levels, coupled with increased hematocrit, suggested a diagnosis of polyclonal gammopathy of undetermined significance.

The patient's macroglobulin levels were found to be within normal limits after completing a course of immunosuppressive therapy.

The presence of macroglobulins in the blood can sometimes be a marker for underlying malignancies, such as multiple myeloma.

Macroglobulin levels were not detected in the patient's serum, indicating that other causes of symptoms might need to be considered.

The patient's macroglobulin levels were significantly reduced after starting a regimen of corticosteroids, suggesting a positive response to treatment.